Prevalence, clinical characteristics and outcome of severe primary HIV-1 infection: A prospective cohort study

Int J Infect Dis. 2019 Nov:88:73-79. doi: 10.1016/j.ijid.2019.08.001. Epub 2019 Aug 8.

Abstract

Background: Severe cases of primary HIV infection have been described in patients presenting with neurological involvement, AIDS defining events or other life-threatening events. These severe forms have not been fully studied.

Objectives: To determine the prevalence and characteristics of severe PHI in a hospital-based cohort of primary HIV infection, and the response to the early initiation of antiretroviral therapy (ART) at 12 months.

Methods: Every patient with PHI attending Hospital Clínic of Barcelona (1997-2015) was evaluated. Severe PHI was defined using clinical, analytical and immunological criteria. Chi-squared test was used for categorical variables and Student's t-test for quantitative variables.

Results: 33% of 224 PHI patients (95% CI: 26.84%-39.16%) had a severe PHI. These patients had more symptoms, abnormal analytical parameters and hospital admissions. The severe PHI group had a significantly higher viral load although no differences were observed at 12 months in terms of viral suppression or CD4 count recovery. None died during PHI.

Conclusions: Up to one third of patients in our cohort presented with a severe PHI, which was associated with higher hospitalization rates and higher plasma HIV RNA viral load. However, severe forms were not associated to a worse clinical, immunological or virological outcome at 12 months.

Keywords: Acute HIV Infection; Early antiretroviral therapy; Primary HIV Infection; Recent HIV Infection; Severity.

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-1 / isolation & purification
  • HIV-1 / physiology
  • Hospitals / statistics & numerical data
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Spain / epidemiology
  • Viral Load

Substances

  • Anti-HIV Agents